|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0218 | ED149055 | General Research Use | No | Female | White | 65 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0238 | ED148796 | General Research Use | No | Male | White | 70 | 6 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_0297 | ED149322 | General Research Use | No | Female | White | 61 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_0315 | ED149030 | General Research Use | No | Male | White | 82 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_0322 | ED149497 | General Research Use | No | Female | White | 80 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0342 | ED148050 | General Research Use | No | Male | White | 64 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0348 | ED148850 | General Research Use | No | Male | White | 71 | 6 - AREDS AMD Severity Scale Step 2 | 10 - Central GA |
| AR2_0394 | ED149101 | General Research Use | No | Female | White | 81 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0458 | ED149258 | General Research Use | No | Male | White | 79 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_0522 | ED148977 | General Research Use | No | Male | White | 68 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0581 | ED148601 | General Research Use | No | Female | White | 70 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0670 | ED149522 | General Research Use | No | Female | White | 83 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_0708 | ED149923 | General Research Use | No | Male | White | 75 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_0795 | ED149267 | General Research Use | No | Male | White | 75 | 10 - Central GA | 10 - Central GA |
| AR2_0951 | ED149107 | General Research Use | No | Female | White | 80 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 10 - Central GA |
| AR2_0990 | ED148895 | General Research Use | No | Male | White | 62 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_1029 | ED149607 | General Research Use | No | Female | White | 64 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1173 | ED148189 | General Research Use | No | Female | White | 78 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1337 | ED148321 | General Research Use | No | Female | White | 78 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1424 | ED148058 | General Research Use | No | Male | White | 78 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |